$0.735
-0.004 (-0.50%)At close
Price Predictions
Open in app to unlock longer-horizon forecasts.
DARE Prediction & Forecast by Similar Chart Analysis
Alphio's DARE stock price prediction model matches the current Dare Bioscience Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $0.74 (+1.15%). The 1-week path is $0.74 (+0.70%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
Should I Buy Dare Bioscience Inc Stock?
DARE is not a good buy right now due to its current price of $0.73, a very low RSI of 20.05 indicating oversold conditions, and a staggering year-to-date decline of 62.31%. The company is facing significant financial challenges, including a negative gross margin of -70.57% in Q2 2026 and a warning about needing to raise capital, which adds to liquidity risks.
DARE stock price ended at $0.74 on Friday, after losing -0.50%
Dare Bioscience Inc (DARE) last closed at $0.735, losing -0.50%. These facts feed the 1-day and 1-week DARE price prediction above.
Analyst Consensus
Dare Bioscience Inc (DARE): 1 buy, 0 hold, 0 sell. Outlook: Strong Buy.
Sell / Buy
Technical signals summary based on buy and sell indicators. The gauge shows the overall market view.
Forecast Drivers
Dare Bioscience Inc (DARE) forecast drivers combine similar chart patterns, seasonality, and moving averages.
Similar patterns
Bearish
Seasonality
Bearish
SMA 20
Bearish
SMA 200
Bearish
Similar Chart Patterns
Stocks whose recent price path most closely matches DARE, ranked by similarity.
Seasonality analysis for DARE
Historically the probability of a positive August return for DARE is 1.59%. June offers the highest probability of a positive month at 65.00%, while September is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.